Literature DB >> 23835602

Computationally designed prodrugs of statins based on Kirby's enzyme model.

Rafik Karaman1, Wajd Amly, Laura Scrano, Gennaro Mecca, Sabino A Bufo.   

Abstract

DFT calculations at B3LYP/6-31G(d,p) for intramolecular proton transfer in Kirby's enzyme models 1-7 demonstrated that the reaction rate is dependent on the distance between the two reacting centers, rGM, and the hydrogen bonding angle, α, and the rate of the reaction is linearly correlated with rGM and α. Based on these calculation results three simvastatin prodrugs were designed with the potential to provide simvastatin with higher bioavailability. For example, based on the calculated log EM for the three proposed prodrugs, the interconversion of simvastatin prodrug ProD 3 to simvastatin is predicted to be about 10 times faster than that of either simvastatin prodrug ProD 1 or simvastatin ProD 2. Hence, the rate by which the prodrug releases the statin drug can be determined according to the structural features of the promoiety (Kirby's enzyme model).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835602     DOI: 10.1007/s00894-013-1929-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  29 in total

1.  Relationship between rate and distance.

Authors:  Fredric M Menger; Ashley L Galloway; Djamaladdin G Musaev
Journal:  Chem Commun (Camb)       Date:  2003-09-21       Impact factor: 6.222

Review 2.  Statins: mechanism of action and effects.

Authors:  C Stancu; A Sima
Journal:  J Cell Mol Med       Date:  2001 Oct-Dec       Impact factor: 5.310

Review 3.  Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.

Authors:  Arik Dahan; Mustafa Khamis; Riad Agbaria; Rafik Karaman
Journal:  Expert Opin Drug Deliv       Date:  2012-06-18       Impact factor: 6.648

4.  Computer-assisted design of pro-drugs for antimalarial atovaquone.

Authors:  Rafik Karaman; Hussein Hallak
Journal:  Chem Biol Drug Des       Date:  2010-08-20       Impact factor: 2.817

Review 5.  Prodrug strategies to overcome poor water solubility.

Authors:  Valentino J Stella; Kwame W Nti-Addae
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 6.  Prodrugs--from serendipity to rational design.

Authors:  Kristiina M Huttunen; Hannu Raunio; Jarkko Rautio
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

7.  A singularity model for chemical reactivity.

Authors:  Fredric M Menger; Rafik Karaman
Journal:  Chemistry       Date:  2010-02-01       Impact factor: 5.236

8.  Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.

Authors:  Rafik Karaman; Khuloud Dajani; Hussein Hallak
Journal:  J Mol Model       Date:  2011-07-23       Impact factor: 1.810

Review 9.  Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.

Authors:  Yanfei Luo; Lishuang Xu; Xiaoguang Tao; Ming Xu; Jia Feng; Xing Tang
Journal:  Drug Dev Ind Pharm       Date:  2012-10-09       Impact factor: 3.225

10.  Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation.

Authors:  Priyanka Pandya; Surendra Gattani; Pankaj Jain; Lokesh Khirwal; Sanjay Surana
Journal:  AAPS PharmSciTech       Date:  2008-12-31       Impact factor: 3.246

View more
  2 in total

Review 1.  Enzyme Models-From Catalysis to Prodrugs.

Authors:  Zeinab Breijyeh; Rafik Karaman
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

2.  Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.

Authors:  Rafik Karaman; Alaa Qtait; Khulod Khayyat Dajani; Saleh Abu Lafi
Journal:  ScientificWorldJournal       Date:  2014-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.